Covaxin effective against both Alpha and Delta variants: US top health institute

bharat biotech covaxin packshot
Source: Bharat Biotech

According to a report by ANI, National Institute of health in US has found that Bharat Biotech’s COVAXIN generates anti-bodies that effectively neutralises both Alpha and Delta variants of COVID-19.

NIH’s statement about COVAXIN

“Results from two studies of blood serum from people who had received CO-VAXIN suggest that the vaccine generates antibodies that effectively neutralize the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the United Kingdom and India, respectively,” ANI quotes NIH as saying.

Also Read

https://surkhiyaa.com/international/mixing-2-doses-of-astrazeneca-pfizer-vaccines-gives-effective-immune-response-oxford-study/

For more Information about vaccination in India visit www.cowin.gov.in

Arjun Singh is the Co-Founder of Surkhiyaa and a youth Journalistic enthusiast who has strong hold on Content Writing and Mass Communication. With a vision of providing short and forthright news, he looks forward to make a difference in Journalism. Arjun can be reached out at as3314177@gmail.com

Leave a Reply

Your email address will not be published.

Translate »
%d bloggers like this: